A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006

European Urology

Volumn 59, Issue 1, 2011, Pages 88-95

  Abdollah, Firas ^a,b   Sun, Maxine ^a   Thuret, Rodolphe ^a,b,c   Jeldres, Claudio ^a,b,c,d,e   Tian, Zhe ^a   Briganti, Alberto ^b   Shariat, Shahrokh F ^d   Perrotte, Paul ^a,b,c,d,e   Rigatti, Patrizio ^b   Montorsi, Francesco ^b   Karakiewicz, Pierre I ^a,b,c,d,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIV MONTPELLIER   (France)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Observation; Prostatic neoplasms mortality; Prostatic neoplasms therapy; Radiotherapy statistics and numerical data; SEER Program; United States epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; GROUPS BY AGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; WATCHFUL WAITING;

EID: 78650251130     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.10.003     Document Type: Article

References (20)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. Y.H. Shao, K. Demissie, and W. Shih Contemporary risk profile of prostate cancer in the United States J Natl Cancer Inst 101 2009 1280 1283
3. D.C. Miller, S.B. Gruber, B.K. Hollenbeck, J.E. Montie, and J.T. Wei Incidence of initial local therapy among men with lower-risk prostate cancer in the United States J Natl Cancer Inst 98 2006 1134 1141
4. A. Bill-Axelson, L. Holmberg, and F. Filen Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial J Natl Cancer Inst 100 2008 1144 1154
5. NCCN Clinical Practice Guidelines in Oncology. Prostate cancer. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/ physician-gls/PDF/prostate.pdf. Accessed September 7, 2010.
6. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
7. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131 (Pubitemid 46726449)
8. L. Liu, A.L. Coker, X.L. Du, J.N. Cormier, C.E. Ford, and S. Fang Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer J Surg Oncol 97 2008 583 591
9. Y.N. Wong, N. Mitra, and G. Hudes Survival associated with treatment vs observation of localized prostate cancer in elderly men JAMA 296 2006 2683 2693
10. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. National Cancer Institute Web site. Bethesda, MD. http://seer.cancer.gov/csr/1975-2004. Accessed September 7, 2010.
11. G.L. Lu-Yao, P.C. Albertsen, and D.F. Moore Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202 1209
12. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Ass 94 1999 496 509
13. J.R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1988 1141 1154
14. H.G. Muller, and J.L. Wang Hazard rate estimation under random censoring with varying kernels and bandwidths Biometrics 50 1994 61 76
15. V. Ficarra, G. Novara, and W. Artibani Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies Eur Urol 55 2009 1037 1063
16. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
17. P.C. Albertsen, J.A. Hanley, and M. Murphy-Setzko Statistical considerations when assessing outcomes following treatment for prostate cancer J Urol 162 1999 439 444
18. J.M. Hollingsworth, D.C. Miller, S. Daignault, and B.K. Hollenbeck Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis Cancer 109 2007 1763 1768
19. A. Kutikov, B.L. Egleston, Y.N. Wong, and R.G. Uzzo Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram J Clin Oncol 28 2010 311 317
20. Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer. In press. DOI:10.1002/cncr.25456.